Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-11

Clinical Trial Update: Assessment of Actigraphy Procedures on the Initiation of an Apomorphine Treatment Delivered Through a Pump to Patients With Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial update evaluating actigraphy procedures during initiation of apomorphine delivered via a pump in patients with Parkinson disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apomorphine (pump-delivered) (apomorphine)

Snippet

Sponsor: Orkyn' | Conditions: Parkinson Disease | NA | Status: UNKNOWN